Nuclear Matrix Protein 22 as Adjunct to Urine Cytology and Cystoscopy in Follow-up of Superficial TCC of Urinary Bladder COMMENT

被引：0
|
作者：
Messing, Edward M. [1 ]
机构：
[1] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
来源：
UROLOGY | 2009年 / 73卷 / 03期
关键词：
CARE PROTEOMIC ASSAY;
D O I：
10.1016/j.urology.2008.12.024
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：596 / 597
页数：2
相关论文
共 50 条
  • [41] DIAGNOSTIC PROBLEMS OF URINE CYTOLOGY ON INITIAL FOLLOW-UP AFTER INTRAVESICAL IMMUNOTHERAPY WITH CALMETTE-GUERIN BACILLUS FAR SUPERFICIAL BLADDER
    MACK, D
    FRICK, J
    UROLOGIA INTERNATIONALIS, 1994, 52 (04) : 204 - 207
  • [42] The Clinical Usefulness of Nuclear Matrix Protein-22 in Patients with Atypical Urine Cytology
    Ahn, Jae Sung
    Kim, Hyun-Soo
    Chang, Sung-Goo
    Jeon, Seung Hyun
    KOREAN JOURNAL OF UROLOGY, 2011, 52 (09) : 603 - 606
  • [43] PROGNOSTIC-SIGNIFICANCE OF URINE CYTOLOGY ON INITIAL FOLLOW-UP AFTER INTRAVESICAL MITOMYCIN-C FOR SUPERFICIAL BLADDER-CANCER
    CANT, JD
    MURPHY, WM
    SOLOWAY, MS
    CANCER, 1986, 57 (11) : 2119 - 2122
  • [44] DIAGNOSTIC VALUE OF NUCLEAR MATRIX PROTEIN-22 (NMP-22) COMPARED WITH URINE CYTOLOGY IN DIAGNOSIS OF BLADDER CARCINOMA AND MUSCULAR INVASION
    Soedarso, M. A.
    Tjahjati, M. I.
    Wahyuni, Y.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E49 - E50
  • [45] Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer
    Abbate, I
    D'Introno, A
    Cardo, G
    Marano, A
    Addabbo, L
    Musci, MD
    Pagliarulo, A
    Correale, M
    Quaranta, M
    ANTICANCER RESEARCH, 1998, 18 (5B) : 3803 - 3805
  • [46] Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer? - experience at Kuwait University
    Kapila, K.
    Kehinde, E. O.
    Anim, J. T.
    Mojiminiyi, O. A.
    Vinsu, A.
    George, S. S.
    Al-Maghrebi, M.
    Al-Mulla, F.
    CYTOPATHOLOGY, 2008, 19 (06) : 369 - 374
  • [47] Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder
    Sözen, S
    Biri, H
    Sinik, Z
    Küpeli, B
    Alkibay, T
    Bozkirli, I
    EUROPEAN UROLOGY, 1999, 36 (03) : 225 - 229
  • [48] Nuclear matrix protein 22 (NMP22):: A tumor marker in primary diagnosis and follow up of bladder cancer.
    Lüdecke, G
    Farkas, P
    Edler, M
    Kraus, S
    Miller, J
    Fischer, C
    Weidner, W
    JOURNAL OF UROLOGY, 1998, 159 (05): : 244 - 244
  • [49] Comparison of the bard Trak™ test with voided urine cytology in the diagnosis and follow-up of bladder tumors
    Chautard, D
    Daver, A
    Bocquillon, V
    Verriele, V
    Colls, P
    Bertrand, G
    Soret, JY
    EUROPEAN UROLOGY, 2000, 38 (06) : 686 - 690
  • [50] THE VALUE OF MICROHEMATURIA, URINE CYTOLOGY, TPA AND NEOPTERINE IN FOLLOW-UP OF PATIENTS WITH BLADDER-CANCER
    MACK, D
    SCHEIBER, K
    RAUSCHMEIER, H
    HAMBERGER, L
    JAKSE, G
    UROLOGIA INTERNATIONALIS, 1987, 42 (05) : 363 - 367
12345